Stay updated on Pembrolizumab and Olaparib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    New revision entry 'Revision: v3.3.3' was added. 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the deletions list.
    Difference
    0.1%
    Check dated 2025-12-23T17:25:28.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 and removed Revision: v3.2.0 along with government funding notices; these changes update site metadata rather than the study details.
    Difference
    0.3%
    Check dated 2025-11-24T18:17:22.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    New version entries in the record history show updated study and recruitment statuses for NCT03976362.
    Difference
    0.0%
    Check dated 2025-11-03T12:53:38.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Minor updates: added a new date (2025-10-16) and a study status line (IPDSharing) for 2025-10-07, while removing an older date (2025-01-16).
    Difference
    0.7%
    Check dated 2025-10-20T06:39:35.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    7%
    Check dated 2025-10-05T17:35:09.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-28T10:52:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.